Elderly psychiatric inpatients were studied to find the prevalence of osteomalacia in those taking anticonvulsant medication (n = 19) and a comparison group not taking these drugs (n = 37). Only one biopsy-proven case was discovered among the anticonvulsant group, and none in the comparison group. This was an unexpectedly low rate. The clinical and biochemical data (including alkaline and acid phosphatase isoenzymes) were further analysed to detect subclinical osteomalacia, but none was found. A difference between the two subgroups was found for total and liver alkaline phosphatase only. The possible explanations for these unexpected findings are discussed. The effect of anticonvulsants on vitamin D and bone metabolism is reviewed and the hypothesis that drug-induced changes in vitamin D metabolism are responsible for the bone changes described in earlier series is questioned.
Introduction
Osteomalacia occurring in association with anticonvulsant drug therapy was described in 1970 by Dent et al.' The mechanism proposed was hepatic microsomal enzyme induction reducing 25-hydroxy vitamin D availability for renal hydroxylation. Anticonvulsant drugs are thus considered to be a risk factor for osteomalacia, and old age is also a further independent risk factor2.
Our attention was drawn to elderly epileptics as a high-risk group when screening a group of 42 inpatients. Three of these patients had the biochemical features of osteomalacia and all were taking anticonvulsants. We therefore decided to look at the prevalence of osteomalacia in a group of elderly patients taking anticonvulsants.
Patients and methods
The study was conducted during the winter months at St Bernard's Psychiatric Hospital, Ealing. It included all patients over the age of 65 who had been taking anticonvulsants for more than 6months. There were 19 such patients, 14 females and 6 males. A comparison group of 37 patients was formed by randomly selecting 1:10 males and 1:15 females from the remaining 462 patients over the age of65 who had been in hospital for more than 6 months. Personal details including length of hospital stay, dietary history, sunlight exposure, drug dosage and duration of therapy were recorded. Fasting blood was taken without stasis and assays were carried out for calcium, phosphate, albumin, total protein, urea, creatinine, total alkaline phosphatase, alkaline phosphatase isoenzymes, total and bone acid phosphatase.
The fraction of the serum alkaline phosphatase contributed by bone is derived from osteoblasts and is a measure of bone formation. Osteoclasts, in contrast, produce acid phosphatase which can be quantified in acidified plasma as the residual activity in the presence of tartrate, and this offers an index of bone resorption.
Ifthe total alkaline phosphatase level was elevated and the serum calcium low, an iliac crest biopsy was performed using a modified Sacker-Nordin trephine. This combination of biochemical abnormalities has been shown to be the best predictor of abnormal histology in the elderly3. Histological assessment of undecalcified bone sections utilized a bright line method of counting osteoid lamellae. The normal number of lamellae in elderly subjects is 3 by this method4.
Results
Five of the anticonvulsant group had low calcium and high alkaline phosphatase values: 4 women underwent biopsy; the single male refused ( Table 1) . One woman clearly had osteomalaciaclinically (bone pain, proximal myopathy), biochemically (bone alkaline phosphate 4 times upper limit of normal, bone acid phosphatase 4 times upper limit of normal) and histologically (11 bright lines visible under polarized light). Bone biopsies from the other 3 did not show abnormally thick osteoid seams as assessed by the number of bright lines, although extensive thin osteoid seams were present. No patient from the comparison group fulfilled the biochemical indications for bone biopsy. Thus the prevalence ofdefinite osteomalacia in the anticonvulsant group was 1:19 (5.5%), which is very similar to that of acutely ill elderly people admitted to a nearby general hospital5. No cases were discovered in the comparison group. This low level was unexpected.
We examined further the demographic and biochemical data for the two groups to confirm that no subelinical cases of osteomalacia had been missed. Data from the one definite case of oesteomalacia was therefore excluded from this part ofthe analysis. The anticonvulsant group were younger than the comparison group. Other demographic characteristics of the two groups were similar. Biochemical characteristics did not differ significantly except for the higher total and liver alkaline phosphatase levels in the anticonvulsant group (Table 2 ). The bone isoenzyme was not elevated in this group, nor were the total or bone acid phosphatase levels. Thus the biochemical results give no further support to the view that anticonvulsant therapy is associated with osteomalacia.
Serum drug levels are generally subtherapeutic despite inpatient supervision. No significant correlations between any biochemical measure and anticonvulsant levels were found. An index of the cumulated consumption of the drugs was obtained 0141-0768/87/ 070425-03/$02.00/0 @ 1987 The Royal Society of Medicine P=0.037 *Log normally distributed CI = confidence intervals by multiplying the daily dose by the duration of therapy. This also failed to correlate with any biochemical result. Sunlight exposure was estimated by a scored questionnaire. No difference between the two groups was found. Nor was there any significant correlation between any biochemical parameter and the sunlight score. Dietary histories were too unreliable for analysis. A history of limb or limb girdle fracture was more common in the epileptic group (P<0.05, X2, Yates' correction). Insofar as could be ascertained retrospectively from the case notes, only one fracture had occurred during a witnessed convulsion.
Discussion
The prevalence of osteomalacia in the institutionalized elderly population was lower than we had anticipated. Our reasons for suspecting that these patients constituted a high-risk group were: (1) the elderly have poor vitamin D intakes6; (2) institutionalized patients of all ages have lower vitamin D levels than comparable persons living at home, and this is not attributable to malabsorption7 8;
(3) anticonvulsant therapy has previously been incriminated1.
Our finding ofonly one clinical case in the epileptic group and none in the comparison group may be the result ofimprovements in diet and environment since the original risk factors were identified. The effect of drug-induced changes in vitamin D status must be distinguished from the other factors known to be important in old age. Sunlight, season, diet, pigmentation and age per se influence the levels of 25hydroxy and 1,25-dihydroxy vitamin D, so that the range for the normal elderly is lower than for young subjects. The effect of disease is to further lower the levels in elderly patients9. However, in elderly patients and those taking anticonvulsant drugs, increases in serum 25-hydroxy vitamin D levels can be found after exposure to ultraviolet light10 l1l
There are also regional variations in the prevalence of osteomalacia which may be attributable to different levels ofsunshine or to racial factors. Early reports of anticonvulsant-associated osteomalacia came from northern Europe where ultraviolet light levels are low for many months of the year, whereas a Nigerian study failed to find any osteomalacia in young epileptics2. Osteomalacia due to simple vitamin D deficiency is commoner in Scotland and the north of England than in the south of England.
An alternative explanation might be that our histological criteria were too rigorous or our method too unsophisticated. The criteria were, however, developed in a comparable population and the potential superiority of more complex methods has not been established. Since asymptomatic 'at risk' paients have failed to benefit from vitamin D supplementation, the pressure to make an early diagnosis is low'3.
A third explanation may be that in the elderly anticonvulsant therapy has less effect on calcium metabolism because liver enzyme induction by these drugs in old age is lessened'4, although some drug effects on microsomal enzyme induction are not reduced 5.
Ifthe effect of anticonvulsants on bone metabolism is mediated solely via the vitamin D system, a satisfactory explanation has not yet been found. There is no agreement on the effect of anticonvulsant therapy on circulating vitamin D metabolite levels'6"7. Serum levels of 25-hydroxy and 1,25-dihydroxy vitamin D in elderly patients are unhelpful in reflecting and predicting histological osteomalacia anyway'8.
There is no agreement either on the time course of the biochemical changes after starting anticonvulsant drugs. Bouillon et al.'9 reported a negative correlation between duration of treatment and low calcium and 25-OH vitamin D levels in patients taking. phenytoin and/or phenobarbitone for very prolonged periods (mean 12, range 2-37 years). Rodbro et al.0, however, reported that such changes as occur do so in the first year oftherapy and stabilize thereafter. We were unable to demonstrate any relationship with any biochemical parameter and duration of therapy.
We would, however, like to pose a more fundamental question: are the described changes in biochemistry and bone histology a form of osteomalacia at all? The concept that anticonvulsants cause a more complex disruption of bone metabolism and structure than does simple vitamin D deficiency has been touched on by a number of authors (e.g. Jubiz has been observed in vitro24. Our finding of higher levels of bone alkaline phosphatase in the anticonvulsant group would suggest that osteoblast activity continues at higher than normal rates in this group, but is not accompanied by the other aecepted histological criteria of osteomalacia.
